ReviewJournal of biomedical science2024

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy.

Dantong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.